Vanguard Value ETF
How Tax Reform Affected Abbott’s 4Q17 Performance
In 4Q17, Abbott Laboratories (ABT) reported $828 million in net losses, which came in at $0.48 per share.
ZBH’s 4Q17 Earnings Results Meet Analysts’ Estimates
Zimmer Biomet Holdings announced its 4Q17 and 2017 results on January 30. The company’s sales exceeded analysts’ estimates, while its adjusted earnings per share managed to meet estimates.
A Look at Johnson & Johnson’s 2018 Guidance
Johnson & Johnson (JNJ) provided 2018 guidance during the company’s earnings results release on January 23, 2018.
Developments in J&J’s Medical Device Business Could Drive Growth
In October 2017, Johnson & Johnson (JNJ) exited its insulin pump business, which was experiencing a decline in sales due to the intense competition in the insulin pump market.
Which Gilead Sciences Portfolio Could Give a Long-Term Boost
NASH is a chronic disease related to steatosis wherein fat accumulates in the liver and can lead to inflammation, progressive fibrosis, and cirrhosis.
Xeljanz Sees Rapid Adoption in 2017
Xeljanz demand trends In 3Q17, Pfizer’s (PFE) Xeljanz reported revenue of ~$348 million, marking YoY (year-over-year) growth of ~48.1%. The drug saw sales of $935 million in the first nine months of 2017, a 44.1% YoY rise. In 3Q17, the drug’s new rheumatology prescriptions rose significantly. In September 2017, Xeljanz accounted for 9.8% of new prescriptions for RA (rheumatoid arthritis) in […]
How Eli Lilly’s Forteo and Jardiance Are Performing
In 3Q17, Eli Lilly’s (LLY) Forteo generated revenues of $441.7 million, ~13% growth on a year-over-year (or YoY) basis and a 1% decline on a quarter-over-quarter basis.
Can Smart Beta Go Wrong?
The smart beta approach aims to benefit from market inefficiencies to deliver higher risk-adjusted returns and improve diversification.
How JNJ’s Medical Devices Business Restructuring Efforts Are Panning Out
In 3Q17, Johnson & Johnson (JNJ) reported ~$19.7 billion in sales. The company’s Medical Devices business generated ~33.5% of the total sales.
ZBH’s Persona Partial Knee Launch Expands Knee Implant Portfolio
On September 11, 2017, Zimmer Biomet Holdings (ZBH) announced the launch of its Persona Partial Knee System.
Jury Hasn’t Decided on ETFs’ Role in Stock Market Rise
Although ETF (VTV) ownership increased substantially during the last 20 years, it still isn’t high enough to meaningfully impact stock prices.
Quest Diagnostics’ Reference Testing, Hospital Outreach Segment
With services offered to about half of the total hospitals, Quest Diagnostics (DGX) has become a leading provider of reference testing services in the United States.
UnitedHealth Group Witnessed Robust Customer Growth in 1Q17
In 1Q17, UnitedHealth Group’s (UNH) UnitedHealthcare business witnessed a 2.5 million year-over-year increase in customers.
OptumRx Continues to Boost UnitedHealth’s Pharmacy Care Services
In its bid to control healthcare costs, UnitedHealth Group’s (UNH) OptumRx segment has been actively deploying data analytics across its Optum platform.
Inside the Latest Capability Advancement in Johnson & Johnson’s Orthopedics
On January 9, JNJ’s Medical Device division announced its Orthopedic Episode of Care Approach, a data-driven program that will accelerate value-based care.
Analyzing Zimmer Biomet Holdings’ Financial Guidance for 2016
Zimmer Biomet revised its 2016 guidance after reporting its 3Q16 earnings. Its guidance for fiscal 2016 is estimated to be $7.63 billion–$7.65 billion.
What’s Fueling the Bull Run? Richard Bernstein Explains
A bull run with legs In Richard Bernstein Advisors’ October Insights newsletter, after dismissing the belief that the Federal Reserve is to blame for stock price inflation (IWD) (VTV), Richard Bernstein moved on to explain the reason for the current bull run. Stating that “fundamentals have improved dramatically, and have been a major support to the […]
Bunge Has Declared a Quarterly Dividend of $0.38 per Share
Bunge (BG) has a market capitalization of $7.7 billion. BG rose by 0.56% to close at $50.0 per share as of March 1, 2016.